immune system news from FierceBioResearcher

Japanese researchers have developed a new approach to make flu vaccines that are able to combat multiple strains of influenza, including strains of the bird flu virus, according to Japan's National Read more...

A protein may hold the key to a new vaccine that could effectively target pneumonia, according to Children's Hospital of Pittsburgh of UPMC. Jay K. Kolls, MD, chief of the Division of Pediatric Read more...

A prostate cancer vaccine developed at the University of Southern California was able to prevent the disease in 90 percent of mice engineered to develop cancer. And the scientists say that the same Read more...

VaxInnate is in a tight race to develop the first "universal" flu vaccine that would be able to tackle a Read more...

Starting off with a batch of donor cells, researchers at Humacyte have developed a collagen matrix from which the cells are then extracted, leaving an 'acellular' material that can be used to craft Read more...

A team of researchers from the U.S. and Germany has found that community associated MRSA, a particularly virulent strain of staph infection, Read more...

Dr. Zheng Cui of Wake Forest University School of Medicine has been given a green light to begin providing transfusions of immune system cells--called granulocytes--to cancer patients. And Dr. Cui Read more...

There's new evidence to support the theory that the enzyme protein kinase G offers a promising target in the fight against tuberculosis. The enzyme is secreted by the microbe that triggers TB and is believed to provide essential protection for the bug from the host's immune system, which tracks down and kills most pathogens. Scientists say they have a compound that can block the protein, but were worried about interfering with the action of other proteins also secreted by the microbe. …

Read more...

Scientists at Japan's National Institute for Longevity Sciences are planning to push an oral Alzheimer's vaccine into clinical trials after reporting that the therapy worked in mice. The institute's director, Takeshi Tabira, says that it may be that the therapy only works at the early stage of development in humans. But when tested in mice, the researchers found that the vaccine reduced beta amyloid in the animals genetically modified to develop Alzheimer's and improved their brain …

Read more...

Researchers at the Swiss Institute of Allergy and Asthma Research say they've developed a vaccine that delivers antigens directly into immune cells. The work could revolutionize allergy treatments, replacing years of injections with a new approach that could work in a matter of weeks. The antigens trigger an immune response, building the body's ability to ward off an allergy. Because antigens are delivered precisely, the new approach also dramatically reduces the amount of vaccine …

Read more...